NCT02217306|Completed
Loading search results
Sponsor study identifier
observational
132
1 country
1
Study Start
January 2014
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
July 2014
Actual (reported)Study Completion
August 2014
Actual (reported)Contrast sensitivity is a tool use to evaluate the visual function in all patients. It can be modified by different pathologies or by age. The purpose of this study is to identify the changes that could be in relationship with the course of diabetic retinopathy comparing with diabetic patient without retinopathy and in patients with diabetic macular edema so if it is a difference, research for therapeutic strategies to improve it in this patients.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
August 2014
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 2014
Date type not reportedThis date has not been verified as actual or estimated.
July 2014
Actual (reported)August 2014
Actual (reported)August 6, 2014
Actual (reported)August 15, 2014
Actual (reported)Contrast Sensitivity
Diabetic patients who are attended at Ophthalmology service in a general hospital undergo to contrast sensitivity test evaluating all frequency by software with 5 spacial frequency (1.5, 3, 6, 12 and 18 cycle grade, Stereoptical Co 1996) in the Visual Basic program.
up to 8 months
Determine changes in contrast sensitivity frequences and visual function (visual acuity) after one month of treatment photocoagulation in macular edema
Diabetic patients attended at Ophthalmology service in a general hospital
Hospital Juarez de Mexico
Mexico City, Mexico City, 07760, Mexico
DULCE MI RAZO BLANCO HERNANDEZ, MD
Hospital Juarez de Mexico
SURISADAI SERAFIN SOLIS, MSc
INSTITUTO POLITECNICO NACIONAL
LOURDES CA ORTEGA LUNA, MSc
INSTITUTO POLITECNICO NACIONAL
VIRGILIO LIMA GOMEZ, MD, MSc
Hospital Juarez de Mexico
132 participants (actual enrollment reported by the registry).
First Submitted
August 6, 2014
First Posted
August 15, 2014
Study Start
January 2014
Date type not reportedThis date has not been verified as actual or estimated.
Intravitreal Bevacizumab for Diabetic Macular Edema
Contact the study team to confirm eligibility.
Primary Completion
July 2014
Actual (reported)Study Completion
August 2014
Actual (reported)Last Updated
August 15, 2014
Record last verified: 2014-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: